Lanean...
Immunotherapy in Pediatric B-Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges
Leukemia, most commonly B-cell acute lymphoblastic leukemia (B-ALL), accounts for about 30% of childhood cancer diagnoses. While there have been dramatic improvements in childhood ALL outcome, certain subgroups, particularly those who relapse, fare poorly. In addition, cure is associated with signif...
Gorde:
| Argitaratua izan da: | Paediatr Drugs |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537790/ https://ncbi.nlm.nih.gov/pubmed/32860590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-020-00413-3 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|